| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | Jolley Julie Diane EVP of Home Health Operations | Sale | -5,586 | -3.91%137,130 | $13.63 | $76,137 | View SEC filing | |
| 2026-03-11 | McQuiddy Collin Chief Accounting Officer | Sale | -1,403 | -26.01%3,991 | $13.61 | $19,095 | View SEC filing | |
| 2025-08-11 | Solomon Ryan Chief Financial Officer | Purchase | +10,000 | +5.45%193,468 | $7.64 | $76,400 | View SEC filing | |
| 2025-03-10 | McQuiddy Collin Chief Accounting Officer | Sale | -1,096 | -100.00%0 | $8.58 | $9,404 | View SEC filing | |
| 2024-12-12 | Bolton Jeffrey Director | Purchase | +4,000 | +4.25%98,144 | $8.69 | $34,760 | View SEC filing | |
| 2024-12-11 | MCGUIGAN STUART M Director | Purchase | +15,000 | +47.15%46,810 | $8.81 | $132,150 | View SEC filing | |
| 2024-11-12 | Bolton Jeffrey Director | Purchase | +10,000 | +11.88%94,144 | $7.72 | $77,177 | View SEC filing | |
| 2024-08-23 | Bolton Jeffrey Director | Purchase | +5,000 | +6.77%78,877 | $8.01 | $40,050 | View SEC filing | |
| 2024-08-12 | Bolton Jeffrey Director | Purchase | +7,000 | +10.47%73,877 | $8.38 | $58,650 | View SEC filing | |
| 2024-05-17 | Bolton Jeffrey Director | Purchase | +10,000 | +23.64%52,299 | $8.33 | $83,300 | View SEC filing | |
| 2024-05-15 | Hoeflinger Erin Director | Purchase | +2,000 | +7.04%30,399 | $9.00 | $18,000 | View SEC filing | |
| 2024-05-10 | Bolton Jeffrey Director | Purchase | +10,000 | +30.96%42,299 | $8.24 | $82,400 | View SEC filing | |
| 2024-03-05 | Langham Ronald Leroy JR EVP Clinical Excel. & Strategy | Sale | -634 | -1.10%57,164 | $8.81 | $5,586 | View SEC filing | |
| 2023-05-31 | Bolton Jeffrey Director | Purchase | +2,000 | +11.37%19,597 | $11.61 | $23,220 | View SEC filing | |
| 2023-05-23 | SHAW L EDWARD JR Director | Purchase | +10,000 | +34.50%38,989 | $11.98 | $119,800 | View SEC filing | |
| 2023-05-22 | Hoeflinger Erin Director | Purchase | +2,100 | +15.44%15,697 | $11.82 | $24,822 | View SEC filing | |
| 2023-05-22 | Langham Ronald Leroy JR EVP Clinical Excel. & Strategy | Purchase | +10,000 | +29.13%44,328 | $11.99 | $119,900 | View SEC filing | |
| 2023-05-18 | Bolton Jeffrey Director | Purchase | +2,000 | +12.82%17,597 | $11.80 | $23,600 | View SEC filing | |
| 2022-11-22 | Bolton Jeffrey Director | Purchase | +1,000 | +6.85%15,597 | $12.69 | $12,690 | View SEC filing | |
| 2022-11-10 | Bolton Jeffrey Director | Purchase | +4,000 | +37.75%14,597 | $12.82 | $51,280 | View SEC filing | |
| 2022-11-09 | HIGDON LEO I JR Director | Purchase | +426 | +5.68%7,926 | $13.57 | $5,781 | View SEC filing | |
| 2022-11-08 | Rush Gregory S Director | Purchase | +10,000 | +151.58%16,597 | $12.67 | $126,713 | View SEC filing | |
| 2022-09-02 | Brown-Stevenson Tina L. Director | Purchase | +1,550 | +19.15%9,645 | $15.99 | $24,785 | View SEC filing | |
| 2022-08-22 | Hoeflinger Erin Director | Purchase | +7,000 | +106.11%13,597 | $13.66 | $95,612 | View SEC filing | |
| 2022-08-19 | Marion Tanya Renee Chief Human Resources Officer | Purchase | +1,712 | +100.00%1,712 | $14.60 | $24,995 | View SEC filing |
1-25 of 34
